Immunotherapy for COVID-19: Evolving treatment of viral infection and associated adverse immunological reactions

This review on COVID-19 immunotherapy enables a comparative analysis of the short-list of currently approved major vaccines. These include the Pfizer and Moderna first mRNA vaccines under FDA purview and the Oxford/AstraZeneca simian adenovirus-vectored vaccine (under UK-MHPRA guidance), all produce...

Descripción completa

Detalles Bibliográficos
Autor principal: Putter, Jeffrey S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881713/
https://www.ncbi.nlm.nih.gov/pubmed/33610448
http://dx.doi.org/10.1016/j.transci.2021.103093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881713/
https://www.ncbi.nlm.nih.gov/pubmed/33610448
http://dx.doi.org/10.1016/j.transci.2021.103093

Ejemplares similares